Literature DB >> 2824329

Correlation of immunocytochemically demonstrated estrogen receptor distribution and histopathologic features in primary breast cancer.

U Berger1, P Wilson, R A McClelland, J Davidson, R C Coombes.   

Abstract

Frozen sections of breast cancer specimens from 114 patients were assayed for the presence of estrogen receptor (ER) with an immunocytochemical method (ERICA). Significant positive correlations were found between receptor status and various pathologic features, including better histologic degrees of differentiation (P less than 0.001), smaller tumor cell size (P = 0.001), and lower levels of either tumor necrosis (P less than 0.001) or lymphocytic infiltration (P less than 0.001). There was a significant relationship between tubular formation and ER positivity (P = 0.003). This study confirms the results from some previous studies in which ER, assessed by biochemical means, has shown a correlation with good-prognosis pathologic features.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2824329     DOI: 10.1016/s0046-8177(87)80411-2

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  7 in total

1.  Assessment of oestrogen receptor content of breast carcinoma by immunohistochemical techniques on fixed and frozen tissue and by biochemical ligand binding assay.

Authors:  D A Paterson; C P Reid; T J Anderson; R A Hawkins
Journal:  J Clin Pathol       Date:  1990-01       Impact factor: 3.411

2.  Immunohistochemical versus biochemical estrogen-receptor and progesterone-receptor analysis: correlation with histological parameters.

Authors:  M Helle; M Helin; J Isola; H Helin
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

3.  Decreased expression of integrin adhesive protein receptors in adenocarcinoma of the breast.

Authors:  M M Zutter; G Mazoujian; S A Santoro
Journal:  Am J Pathol       Date:  1990-10       Impact factor: 4.307

4.  Comparison of immunocytochemical and biochemical assays for estrogen receptor in fine needle aspirates and histologic sections from breast carcinomas.

Authors:  R L Katz; S Patel; N Sneige; H A Fritsche; G N Hortobagyi; F C Ames; T Brooks; N G Ordonez
Journal:  Breast Cancer Res Treat       Date:  1990-05       Impact factor: 4.872

5.  Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100.

Authors:  Bryan P Schneider; Molin Wang; Milan Radovich; George W Sledge; Sunil Badve; Ann Thor; David A Flockhart; Bradley Hancock; Nancy Davidson; Julie Gralow; Maura Dickler; Edith A Perez; Melody Cobleigh; Tamara Shenkier; Susan Edgerton; Kathy D Miller
Journal:  J Clin Oncol       Date:  2008-10-01       Impact factor: 44.544

6.  Immunohistochemical evaluation of human epidermal growth factor receptor 2 and estrogen and progesterone receptors in breast carcinoma in Jordan.

Authors:  Nidal M Almasri; Mohammad Al Hamad
Journal:  Breast Cancer Res       Date:  2005-05-24       Impact factor: 6.466

7.  Morphometric grading of breast cancer: thresholds for tubular differentiation.

Authors:  P Kronqvist; T Kuopio; Y Collan
Journal:  Br J Cancer       Date:  2000-05       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.